The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
Author:
Affiliation:
1. Department of Hematology and Hematopoietic Cell Transplantation City of Hope National Medical Center Duarte California
2. Division of Hematologic Malignancies Memorial Sloan Kettering Cancer Center New York New York
Funder
NIH Clinical Center
Publisher
Wiley
Subject
Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26146
Reference6 articles.
1. RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years
2. Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia
3. Molecular Minimal Residual Disease in Acute Myeloid Leukemia
4. Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia
5. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML;Blood Advances;2024-06-14
2. RAS G12C Inhibitors: Three Birds with One Stone;Cancer Discovery;2024-05-01
3. Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML;Leukemia;2024-02-20
4. Impact of KRAS and NRAS mutations on outcomes in acute myeloid leukemia;Leukemia & Lymphoma;2023-04-12
5. Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC ‐defining criteria, TP53 allelic state, or TP53 variant allele frequency;Cancer Medicine;2022-11-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3